ArticleWorld journal of oncology2024

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells.

Tina Al-Janaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.